Quick Answer
Ocean Biomedical, Inc. reported R&D Expense of $26.0 thousand for fiscal year 2024.
Ocean Biomedical, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $26.0K | -96.3% |
| 2023 | $709.0K | -91.6% |
| 2022 | $8.41M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2025 | $18.0K | -30.8% | -30.8% |
| March 31, 2024 | $26.0K | -93.4% | -91.5% |
| September 30, 2023 | $305.0K | -83.6% | +989.3% |
| June 30, 2023 | $28.0K | -99.1% | -92.9% |
| March 31, 2023 | $393.0K | -87.7% | -78.8% |
| September 30, 2022 | $1.86M | — | -41.8% |
| June 30, 2022 | $3.19M | — | -0.2% |
| March 31, 2022 | $3.20M | — | — |
- Ocean Biomedical, Inc. showed a decrease of -96.3% in R&D Expense compared to the prior fiscal year.
- Over the 2022–2024 period, Ocean Biomedical, Inc.’s r&d expense has declined by 99.7% (from $8.41 million to $26.0 thousand).
- The most recent figure is from Ocean Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 8, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: